Indocyanine green fluorescence lymphatic node mapping for gastric cancer

Indocyanine green fluorescence lymphatic node mapping for gastric cancer - Indocyanine green fluorescence lymphatic node mapping for gastric cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031546

Enrollment

100

Registered

2018-04-01

Start date

2018-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Lymphatic vessel imaging by indocyanine green fluorescence imaging

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient receiving gastrectomy at University of Tokyo Hospital, who meets the following criteria 1) Tumor diameter 40mm and smaller 2) age 20 years and older 3) PS(ECOG Performance status) 0 or 1 4) Preserved main organ function 5) Written Informed consent under patients will

Exclusion criteria

Exclusion criteria: 1) Past history of hypersensitivity to indocyanine green 2) Past history of hypersensitivity to iodine 3) Under or with will of pregnancy 4) Nursing

Design outcomes

Primary

Measure	Time frame
False negative rate of IGFI on pathological lymph node metastasis	—

Countries

Japan

Contacts

Public ContactIwata Ryohei

Graduate school of Medicine, University of Tokyo Hospital Gastrointestinal surgery

IWATAR-SUR@h.u-tokyo.ac.jp03-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026